Mitochondrial biogenesis
|
MTX |
Folate-dependent ↓ |
Inhibits mitochondrial folate synthesis |
Inhibits synovial cell proliferation |
(144) |
Quercetin |
PGC-1α ↓ |
Promotes mtDNA |
Inhibits TNF-α, IL-6, etc. |
(39) |
Resveratrol |
PGC-1α ↓ |
Promotes mtDNA |
Corrects RA metabolic disorders |
(40) |
2-DG |
Glycolysis ↓ |
Activates AMPK and improves energy metabolism |
Inhibits NF-κB |
(148) |
Tofacitinib |
JAK ↓ |
Reverses mitochondrial membrane potential |
Lowers glycolytic enzyme genes |
(152) |
IRF9 |
SIRT1 ↑ |
Reverses mitochondrial membrane potential and increases in membrane permeability |
NF-κB inhibition and pro-apoptosis |
(151) |
Cantleyoside |
SIRT1 ↑ |
Suppresses OCR and ECAR |
NF-κB inhibition and pro-apoptosis |
(151) |
Metformin |
ETC complexes ↑ |
Reduces mitochondrial activity and ATP production |
Inhibits synovial cell proliferation |
(153) |
Mitochondrial dynamics
|
mdivi-1 |
DNM1L ↓ |
Promotes mitochondrial division |
Promotes apoptosis of synovial cells |
(83) |
Leflunomide |
DHODH ↓ |
Inhibits DHODH, promotes Mfn1, Mfn2, and increases mitochondrial fusion |
Reduces oxidative stress and inhibits proliferation |
(143) |
Sulfasalazine |
|
Increases mitochondrial membrane permeability |
Induces T-cell apoptosis |
(144) |
TNF-a inhibitor |
TNF-a ↓ |
Reduces mitochondrial division |
Reduces oxidative stress |
(109) |
Icariside |
|
Reverses mitochondrial membrane potential |
Induces RA-FLS apoptosis |
(120) |
7-HT |
|
Enhances mitochondrial pathway Bax/Bcl-2 |
Induces apoptosis in FLS cells |
(121) |
β-Elmene |
|
Phosphorylates MAPK pathway |
Induces apoptosis |
(123) |
Mitochondrial autophagy
|
5-azacytidine |
Methylation ↓ |
Enhances PINK1-mediated mitochondrial autophagy |
Inhibits cytokines and chemokines |
(65) |
Rapamycin |
mTOR ↑ |
Enhances mitochondrial autophagic activity in synovial cells |
Inhibits cytokines |
(154) |